צמיחת הכנסות ב-12 חודשים נגררים: Allurion Technologies (ALUR)

Year-over-year sales volatility over a rolling 12-month period demonstrates the current trend, where the indicator value reaches -50.20. Allurion Technologies (ALUR) revenues are based on the supply of non-surgical weight loss capsules, which create a steady order flow. Despite pressure from new injectable drugs, the company maintains its position through digital monitoring and procedural simplicity, which mitigates market volatility.
Allurion Corp (ALUR) - פילוחי מדדים ודוחות פיננסיים

This indicator measures revenue dynamics over a rolling twelve-month period, neutralizing seasonal distortions from single reports to assess cash flow stability. For Allurion Technologies (ALUR), this is a critical marker of capsule technology expansion amid intense pressure from weight-loss drugs. By analyzing relative revenue growth over four quarters compared to the previous year, an investor determines the effectiveness of market niche protection. A positive trend confirms the demand for the non-surgical method; however, without accounting for the debt load, the risk of capital freeze remains significant.